FR1484M - New drug in particular for the treatment of inflammatory manifestations of microbial origin. - Google Patents

New drug in particular for the treatment of inflammatory manifestations of microbial origin.

Info

Publication number
FR1484M
FR1484M FR870557A FR870557A FR1484M FR 1484 M FR1484 M FR 1484M FR 870557 A FR870557 A FR 870557A FR 870557 A FR870557 A FR 870557A FR 1484 M FR1484 M FR 1484M
Authority
FR
France
Prior art keywords
treatment
new drug
microbial origin
inflammatory manifestations
manifestations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR870557A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR870557A priority Critical patent/FR1484M/en
Priority to GB30827/62A priority patent/GB949434A/en
Application granted granted Critical
Publication of FR1484M publication Critical patent/FR1484M/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR870557A 1961-08-10 1961-08-10 New drug in particular for the treatment of inflammatory manifestations of microbial origin. Active FR1484M (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR870557A FR1484M (en) 1961-08-10 1961-08-10 New drug in particular for the treatment of inflammatory manifestations of microbial origin.
GB30827/62A GB949434A (en) 1961-08-10 1962-08-10 Therapeutic antibacterial compositions comprising antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR870557A FR1484M (en) 1961-08-10 1961-08-10 New drug in particular for the treatment of inflammatory manifestations of microbial origin.

Publications (1)

Publication Number Publication Date
FR1484M true FR1484M (en) 1962-09-17

Family

ID=8761090

Family Applications (1)

Application Number Title Priority Date Filing Date
FR870557A Active FR1484M (en) 1961-08-10 1961-08-10 New drug in particular for the treatment of inflammatory manifestations of microbial origin.

Country Status (2)

Country Link
FR (1) FR1484M (en)
GB (1) GB949434A (en)

Also Published As

Publication number Publication date
GB949434A (en) 1964-02-12

Similar Documents

Publication Publication Date Title
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR3244M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR341M (en) New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR28F (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR2805M (en) New drug in particular for the treatment of affections of bacterial origin.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR3316M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR1946M (en) New drug in particular for the treatment of spasms of coronary origin.